
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>Acetylsalicylic acid</td><td>Allopurinol</td><td>The therapeutic efficacy of Allopurinol can be decreased when used in
combination with Acetylsalicylic acid.</td></tr><tr><td>Atazanavir</td><td>Acetylsalicylic acid</td><td>The risk or severity of nephrotoxicity can be increased when Acetylsalicylic
acid is combined with Atazanavir.</td></tr><tr><td>Atazanavir</td><td>Allopurinol</td><td>Atazanavir may decrease the excretion rate of Allopurinol which could result in
a higher serum level.</td></tr><tr><td>Atazanavir</td><td>Cholecalciferol</td><td>The metabolism of Cholecalciferol can be decreased when combined with
Atazanavir.</td></tr><tr><td>Atazanavir</td><td>Colchicine</td><td>The serum concentration of Colchicine can be increased when it is combined with
Atazanavir.</td></tr><tr><td>Atazanavir</td><td>Dexibuprofen</td><td>The risk or severity of nephrotoxicity can be increased when Atazanavir is
combined with Dexibuprofen.</td></tr><tr><td>Atazanavir</td><td>Dolutegravir</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Atazanavir.</td></tr><tr><td>Atazanavir</td><td>Rosuvastatin</td><td>The serum concentration of Rosuvastatin can be increased when it is combined
with Atazanavir.</td></tr><tr><td>Atazanavir</td><td>Tamsulosin</td><td>The metabolism of Tamsulosin can be decreased when combined with Atazanavir.</td></tr><tr><td>Cobicistat</td><td>Allopurinol</td><td>Cobicistat may decrease the excretion rate of Allopurinol which could result in
a higher serum level.</td></tr><tr><td>Cobicistat</td><td>Colchicine</td><td>The serum concentration of Colchicine can be increased when it is combined with
Cobicistat.</td></tr><tr><td>Cobicistat</td><td>Rosuvastatin</td><td>Cobicistat may decrease the excretion rate of Rosuvastatin which could result in
a higher serum level.</td></tr><tr><td>Colchicine</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Colchicine which could
result in a higher serum level.</td></tr><tr><td>Colchicine</td><td>Allopurinol</td><td>Allopurinol may decrease the excretion rate of Colchicine which could result in
a higher serum level.</td></tr><tr><td>Dexibuprofen</td><td>Acetylsalicylic acid</td><td>Dexibuprofen may decrease the antiplatelet activities of Acetylsalicylic acid.</td></tr><tr><td>Dexibuprofen</td><td>Allopurinol</td><td>Dexibuprofen may decrease the excretion rate of Allopurinol which could result
in a higher serum level.</td></tr><tr><td>Dexibuprofen</td><td>Colchicine</td><td>Dexibuprofen may decrease the excretion rate of Colchicine which could result in
a higher serum level.</td></tr><tr><td>Dexibuprofen</td><td>Rosuvastatin</td><td>The metabolism of Dexibuprofen can be decreased when combined with Rosuvastatin.</td></tr><tr><td>Dolutegravir</td><td>Allopurinol</td><td>The excretion of Allopurinol can be decreased when combined with Dolutegravir.</td></tr><tr><td>Dolutegravir</td><td>Cobicistat</td><td>Cobicistat may decrease the excretion rate of Dolutegravir which could result in
a higher serum level.</td></tr><tr><td>Dolutegravir</td><td>Colchicine</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Colchicine.</td></tr><tr><td>Dolutegravir</td><td>Rosuvastatin</td><td>The excretion of Rosuvastatin can be decreased when combined with Dolutegravir.</td></tr><tr><td>Dolutegravir</td><td>Umeclidinium</td><td>The serum concentration of Umeclidinium can be increased when it is combined
with Dolutegravir.</td></tr><tr><td>Rosuvastatin</td><td>Allopurinol</td><td>The excretion of Allopurinol can be decreased when combined with Rosuvastatin.</td></tr><tr><td>Rosuvastatin</td><td>Colchicine</td><td>Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.</td></tr><tr><td>Tamsulosin</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Tamsulosin which could
result in a higher serum level.</td></tr><tr><td>Tamsulosin</td><td>Allopurinol</td><td>Allopurinol may decrease the excretion rate of Tamsulosin which could result in
a higher serum level.</td></tr><tr><td>Tamsulosin</td><td>Cholecalciferol</td><td>The metabolism of Tamsulosin can be decreased when combined with
Cholecalciferol.</td></tr><tr><td>Tamsulosin</td><td>Cobicistat</td><td>The metabolism of Tamsulosin can be decreased when combined with Cobicistat.</td></tr><tr><td>Tamsulosin</td><td>Colchicine</td><td>Tamsulosin may decrease the excretion rate of Colchicine which could result in a
higher serum level.</td></tr><tr><td>Tamsulosin</td><td>Dexibuprofen</td><td>Dexibuprofen may decrease the excretion rate of Tamsulosin which could result in
a higher serum level.</td></tr><tr><td>Tamsulosin</td><td>Umeclidinium</td><td>The metabolism of Umeclidinium can be decreased when combined with Tamsulosin.</td></tr><tr><td>Umeclidinium</td><td>Cholecalciferol</td><td>The metabolism of Umeclidinium can be decreased when combined with
Cholecalciferol.</td></tr><tr><td>Umeclidinium</td><td>Cobicistat</td><td>The serum concentration of Umeclidinium can be increased when it is combined
with Cobicistat.</td></tr><tr><td>Umeclidinium</td><td>Colchicine</td><td>The serum concentration of Umeclidinium can be increased when it is combined
with Colchicine.</td></tr></tbody></table></div>
